Abstract
RBP2 has been found to actively participate in cancer progression. It inhibits the senescence of cancer cells, mediates cancer cell proliferation and promotes cancer metastasis. It is also essential to drug tolerance. However, the effects of RBP2 on epithelial-mesenchymal transition are still unknown. In this study, we analyzed the effects of RBP2 on epithelial-mesenchymal transition in non-small cell lung cancer. The results showed that RBP2 down-regulated the expression of E-cadherin by inhibiting the promoter activity of E-cadherin and up-regulated the expression of N-cadherin and snail via the activation of Akt signaling, and the overexpression of RBP2 induced epithelial-mesenchymal transition in non-small cell lung cancer cells. Our study further indicated that RBP2 may be a potential target for anti-lung cancer therapy.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Blotting, Western
-
Cadherins / metabolism
-
Carcinoma, Non-Small-Cell Lung / metabolism
-
Carcinoma, Non-Small-Cell Lung / physiopathology*
-
DNA Primers / genetics
-
Epithelial-Mesenchymal Transition / physiology*
-
Fluorescent Antibody Technique
-
Gene Expression Regulation, Neoplastic / genetics
-
Gene Expression Regulation, Neoplastic / physiology*
-
Humans
-
Immunohistochemistry
-
Luciferases
-
RNA Interference
-
RNA, Small Interfering / genetics
-
Real-Time Polymerase Chain Reaction
-
Retinol-Binding Proteins, Cellular / metabolism*
-
Snail Family Transcription Factors
-
Transcription Factors / metabolism
Substances
-
Cadherins
-
DNA Primers
-
RBP2 protein, human
-
RNA, Small Interfering
-
Retinol-Binding Proteins, Cellular
-
Snail Family Transcription Factors
-
Transcription Factors
-
Luciferases
Grants and funding
This work was supported by the Natural Science Foundation of Shandong Province [Z2005C02]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.